SLGL
SLGL clinical trials: Sol-Gel Technologies Ltd.
Every trial on ClinicalTrials.gov where Sol-Gel Technologies Ltd. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 15
- Trials linked
- 15
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
SLGL on the catalyst calendar · SLGL registry changes
- Primary completion Aug 20, 2026ActualPhase 3NCT06050122Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin SyndromeSol-Gel Technologies, Ltd. · Gorlin SyndromeCompletedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 23, 2021ActualPhase 2NCT04155190A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients...Sol-Gel Technologies, Ltd. · Recurrent Basal Cell CarcinomaTerminatedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 14, 2021ActualPhase 3NCT04308395Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)Sol-Gel Technologies, Ltd. · Basal Cell Nevus SyndromeTerminatedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 28, 2020ActualPhase 3NCT03703310Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in...Sol-Gel Technologies, Ltd. · Basal Cell Nevus SyndromeCompletedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 15, 2021ActualPhase 1NCT05675501Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical PropertiesSol-Gel Technologies, Ltd. · Papulopustular RosaceaCompletedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 23, 2019ActualPhase 3NCT03761810A Study of S6G5T3 in the Treatment of Acne VulgarisSol-Gel Technologies, Ltd. · Acne VulgarisCompletedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2019ActualPhase 3NCT03761784A Study of S6G5T-3 in the Treatment of Acne VulgarisSol-Gel Technologies, Ltd. · Acne VulgarisCompletedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 13, 2019ActualPhase 3NCT03564145A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular RosaceaSol-Gel Technologies, Ltd. · Papulopustular RosaceaTerminatedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 10, 2019ActualPhase 3NCT03564119A Study of S5G4T-1 in the Treatment of Papularpustular RosaceaSol-Gel Technologies, Ltd. · Papulopustular RosaceaCompletedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 24, 2019ActualPhase 3NCT03448939A Study of S5G4T-1 in the Treatment of Papulopustular RosaceaSol-Gel Technologies, Ltd. · Papulopustular RosaceaCompletedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2017ActualPhase 2NCT02842021Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea PedisSol-Gel Technologies, Ltd. · Tinea PedisTerminatedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 6, 2020ActualPhase 1NCT04059523MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3Sol-Gel Technologies, Ltd. · Acne VulgarisCompletedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 19, 2019ActualPhase 3NCT03727074Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) CreamSol-Gel Technologies, Ltd. · Actinic Keratosis (AK)CompletedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2017ActualPhase 2NCT02661958Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne VulgarisSol-Gel Technologies, Ltd. · Acne VulgarisCompletedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2012ActualPhase 2NCT00940992A Study of DER 45-EV Gel to Treat RosaceaSol-Gel Technologies, Ltd. · RosaceaCompletedSLGLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 15 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner